Ee Mode Assists Clinicians To Detect Malignancy That May Otherwise Go Undiscovered Or Misclassified About See Technologies Applies Cutting Edge Deep Learning And Computational Modeling Techniques On Medical Images Empower Improve Their Clinical Workflow Patient Outcomes 39s First Product News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MELBOURNE, Australia, Nov. 17, 2022 /PRNewswire/ See-Mode Technologies, a MedTech company based in Australia that is on a mission to unlock the hidden insights within medical imaging, today announced that it has received approval from Health Canada for its product expansion to support Breast & Thyroid ultrasound examinations. See-Mode uses Artificial Intelligence to detect lesions in ultrasound images, then assigns feature classifications to each lesion, in line with the American College of Radiology's BI-RADS and TI-RADS rating systems. Sonographer worksheets, complete with lesion classifications and diagrams are instantly generated and sent to PACS, while preliminary impressions are sent to radiology reporting systems. In follow-up scans, See-Mode allows for fast comparison between old and new images, and will automatically highlight changes in lesion characteristics. "Receiving approval from Health Canada is a significant step forward for us at See-Mode, which demonst

Milad mohammadzadehMartin necasAmerican college of radiologyHealth canadaMode technologiesArtificial intelligenceAmerican collegeSpecialist sonographerWaikato hospitalClinical consultantNov 17022 prnewswire see mode technologiesA medtech company based in australia that is ona mission to unlock the hidden insights within medical imagingOday announced that it has received approval from health canada for its product expansion to support breast amp thyroid ultrasound examinations see mode uses artificial intelligence detect lesions in imagesHen assigns feature classifications to each lesionN line with the american college of radiology 39s bi rads and ti rating systems sonographer worksheets